At a glance
ClinicalIndex Comparison RecordN/ACompleted· 34 enrolled
Drug / intervention
transcranial alternating current stimulation (tACS)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Improving Memory Functions in Mild Alzheimer's Disease by Transcranial Alternating Current Stimulation
In Brief
A clinical study evaluating transcranial alternating current stimulation (tACS) for Alzheimer Disease. Completed, enrolled 34 participants across 1 site.
Detailed Summary
The overall objective of this project is to examine the effects of non-invasive brain stimulation on episodic memory performance
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlzheimer Disease
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartJun 2020
First PostedMar 2021
Primary CompletionSep 2023
TodayJul 2026
First PostedMar 5, 2021
Enrollment StartJun 22, 2020
Primary CompletionSep 30, 2023
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 5.3 years ago
Interventions
transcranial alternating current stimulation (tACS)device
The tACS intervention (gamma stimulation, theta stimulation and active sham condition) will be administered to the participants over three visits that will be completed within one of the working days (Mon-Fri) at approximately the same time of day for all participants. Participants will be randomized and blinded to the tACS treatment.